Articles by Natalie Grover

Natalie Grover

Latest from this author

FDA Seeks More Data On Sarepta Muscle Disorder Drug, Shares Slump

Sarepta Therapeutics Inc said the U.S. Food and Drug Administration had asked for additional data on its lead drug, delaying its marketing application by about six months.
    MOST Read
    1. Albertsons Issues Recall of Pasta Salads, Deli Meals Across Multiple States
    2. Starbucks Protein Drink Caffeine Content, Calories: Is the 'Proffee' Craze Worth It?
    3. Mars Secures FTC Approval for $36 Billion Kellanova Acquisition
    4. Starbucks Fall Menu 2025 Release Date Revealed: All the New Drinks You'll Want to Try First
    5. Krispy Kreme's Harry Potter Doughnuts Aren't Out Yet — But These Magical Treats Are Available Now
    News